Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CORT | CORCEPT THERAPEUTICS INC | $91.57 | $23.68 | 286.70% | 199.07x | 153.46x | 12.43x | 15.41x | 1.42x | $119.79M | 1.25% | $637.99M | 6.11 | $9.73B | -1,417.29 | ||
| LQDA | LIQUIDIA CORP | $77.08 | $17.29 | 345.79% | 321.17x | 23.20x | 23.55x | 63.13x | 1.58x | $41.15M | 0.61% | $108.58M | 1.23 | $6.81B | 127.18 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $272.67 | $93.15 | 192.73% | 62.54x | 36.29x | 8.45x | 33.85x | 1.27x | $641.34M | 1.77% | $1.08B | 8.09 | $37.66B | 40.74 | ||
| XERS | XERIS BIOPHARMA HOLDINGS INC | $8.60 | $2.77 | 210.81% | 122.86x | 76.65x | 4.66x | 114.11x | 1.18x | $47.52M | 3.24% | $13.01M | 0.08 | $1.63B | 30.54 | ||
| KRYS | KRYSTAL BIOTECH INC | $339.22 | $93.16 | 264.12% | 43.77x | 43.72x | 23.81x | 7.83x | 2.10x | $237.38M | 2.39% | $1.28B | 43.59 | $9.51B | 44.44 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $62.58 | $16.98 | 268.47% | 63.86x | 49.02x | 6.35x | 7.95x | 1.73x | $164.23M | 3.43% | $605.69M | 7.92 | $4.63B | 41.56 | ||
| ADMA | ADMA BIOLOGICS INC | $8.75 | $9.02 | -3.02% | 12.68x | 10.43x | 4.05x | 5.20x | 0.53x | $107.90M | 5.22% | $390.33M | 1.65 | $2.09B | 9.42 | ||
| HALO | HALOZYME THERAPEUTICS INC | $77.09 | $69.92 | 10.25% | 26.04x | 9.28x | 6.04x | 41.63x | 0.46x | $667.65M | 7.33% | $219.64M | 1.86 | $10.98B | 17.60 | ||
| RPRX | ROYALTY PHARMA PLC | $57.30 | $39.82 | 43.87% | 30.00x | 10.68x | 10.26x | 3.32x | 0.63x | $2.34B | 9.35% | $9.94B | 22.75 | $41.36B | 35.55 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $59.11 | $38.40 | 53.93% | 42.22x | 16.00x | 3.51x | 1.84x | 0.62x | $767.06M | 6.74% | $6.21B | 32.27 | $9.78B | 20.28 | ||
| VCEL | VERICEL CORP | $45.88 | $8.96 | 412.15% | 106.70x | 95.17x | 7.97x | 6.58x | 2.24x | $47.49M | 2.04% | $356.23M | 7.02 | $2.33B | 57.60 | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $243.47 | $48.27 | 404.37% | 518.02x | 9.40x | 3.40x | 3.37x | 1.75x | $1.30B | 8.61% | $4.53B | 73.22 | $18.83B | 27.90 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $293.99 | $96.45 | 204.80% | 37.21x | 32.10x | 21.30x | 5.91x | 1.74x | $122.22M | 2.09% | $997.32M | 50.16 | $6.23B | 27.62 | ||
| ASND | ASCENDIS PHARMA A | $251.76 | $78.78 | 219.56% | 26.68x | 17.31x | 15.35x | 27.24x | 2.76x | $52.94M | 0.34% | $574.09M | 9.24 | $16.02B | 171.77 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $33.50 | $34.98 | -4.23% | 13.24x | 8.90x | 2.15x | 2.13x | 0.50x | $341.79M | 17.64% | $910.35M | 15.75 | $1.51B | 6.37 | ||
| SPRO | SPERO THERAPEUTICS INC | $1.44 | $8.80 | -83.64% | 5.33x | -4.87x | 1.35x | 1.58x | 0.06x | $7.24M | 8.75% | $52.93M | 0.92 | $29.72M | 1.92 | ||
| TECH | BIO-TECHNE CORP | $71.64 | $16.42 | 336.21% | 100.90x | 34.34x | 9.25x | 5.38x | 1.85x | $269.60M | 2.41% | $2.09B | 13.34 | $11.30B | 44.13 | ||
| TGTX | TG THERAPEUTICS INC | $53.96 | $21.36 | 152.60% | 16.76x | 38.23x | 11.13x | 14.17x | 3.76x | -$14.19M | -0.18% | $583.13M | 4.04 | $8.57B | 57.12 | ||
| EXEL | EXELIXIS INC | $55.53 | $30.49 | 82.14% | 17.80x | 17.04x | 6.04x | 7.21x | 1.27x | $917.69M | 6.40% | $1.94B | 7.49 | $13.90B | 13.16 | ||
| UTHR | UNITED THERAPEUTICS CORP | $529.34 | $235.35 | 124.91% | 18.08x | 19.39x | 7.26x | 3.81x | 2.07x | $1.02B | 4.42% | $5.90B | 135.66 | $21.19B | 12.37 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $480.50 | $163.56 | 193.77% | 28.25x | 24.85x | 9.99x | 6.30x | 2.09x | $3.71B | 3.04% | $19.36B | 76.20 | $118.45B | 21.96 | ||
| NAGE | NIAGEN BIOSCIENCE INC | $3.37 | $2.08 | 61.74% | 14.04x | 14.47x | 2.06x | 3.26x | 1.32x | $4.11M | 1.51% | $82.33M | 1.03 | $204.43M | 9.62 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $672.15 | $425.94 | 57.80% | 15.79x | 14.38x | 4.69x | 2.24x | 1.07x | $4.11B | 5.88% | $31.42B | 302.15 | $70.21B | 12.22 | ||
| VCYT | VERACYTE INC | $57.26 | $8.84 | 547.71% | 51.59x | 51.64x | 8.41x | 3.40x | 6.07x | $155.34M | 3.41% | $1.34B | 16.90 | $4.34B | 37.75 | ||
| INCY | INCYTE CORP | $115.65 | $64.66 | 78.87% | 15.86x | 14.51x | 4.30x | 4.11x | 1.41x | $1.45B | 6.29% | $5.62B | 28.21 | $19.68B | 10.52 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.